
OxyContin maker Purdue Pharma and a group of states have not been able to agree on a multibillion-dollar settlement of lawsuits over the drug's role in the opioid crisis after more than a month of mediation.
A mediator could call for still more talks between the parties, Purdue lawyer Marshall Huebner said at a hearing Thursday, indicating there could be a call for further mediation.